| Literature DB >> 33238348 |
Seongwon Lee1, Sangho Oh2, Daegu Son1.
Abstract
BACKGROUND: The aim of this study was to analyze the clinical results of minimal single palmar-incision carpal tunnel release without a tourniquet.Entities:
Keywords: Carpal tunnel syndrome; Hand; Median nerve; Nerve compression syndrome; Tourniquet
Year: 2020 PMID: 33238348 PMCID: PMC7700870 DOI: 10.5999/aps.2020.01732
Source DB: PubMed Journal: Arch Plast Surg ISSN: 2234-6163
Fig. 1.Preoperative design
Kaplan’s cardinal and longitudinal lines are drawn from the ulnar side of the middle finger. The expected proximal and distal ends of the transverse carpal ligament are drawn. Based on these lines, the incisional line is drawn.
Fig. 2.Transverse carpal ligament release
(A) After dissection, the subcutaneous fat is spread using blunt Metzenbaum scissors and the palmar fascia is seen. (B) The transverse carpal ligament is completely resected.
Fig. 3.Median nerve blood flow change
(A) Immediately after partial release of the transverse carpal ligament (TCL), the median nerve appeared pale. (B) Immediately after complete release of the TCL, the blood flow to the median nerve increased, which could be visualized.
Demographics of patient groups with and without a bleeding tendency
| Characteristics | BT group | Non-BT group | P-value |
|---|---|---|---|
| No. of cases | 15 | 75 | |
| Age (yr) | 67.5 ± 10.5 | 61.2 ± 10.1 | 0.002[ |
| Sex | |||
| Female | 7 (46.7) | 69 (92.0) | < 0.001[ |
| Male | 8 (53.3) | 6 (8.0) | |
| Laterality | |||
| Right | 8 (53.3) | 38 (50.7) | 0.850[ |
| Left | 7 (46.7) | 37 (49.3) | |
| Diabetes | 5 (33.3) | 13 (17.3) | 0.157[ |
| Hypertension | 13 (86.7) | 21 (28) | < 0.001[ |
| NCV | 0.023[ | ||
| Mild (grade 2) | 0 | 4 (5.3) | |
| Moderate (grade 3) | 1 (6.7) | 23 (30.7) | |
| Severe (grade 4) | 5 (33.3) | 9 (12.0) | |
| Very severe (grade 5) | 2 (13.3) | 9 (12.0) | |
| Extremely severe (grade 6) | 2 (13.3) | 22 (29.3) | |
| No data | 5 (33.3) | 8 (10.7) | |
| Mean follow-up (day) | 33.4 | 103.6 |
Values are presented as mean±SD or number (%).
BT, bleeding tendency; NCV, nerve conduction velocity.
Independent t-test;
Chi-square test;
Fisher exact test.
Demographics of patients participating in the BCTQ survey
| Characteristics | BT group | Non-BT group | P-value |
|---|---|---|---|
| No. of cases | 6 | 34 | |
| Age (yr) | 62.7 ± 5.9 | 58.3 ± 8.8 | 0.247[ |
| Sex | |||
| Female | 3 (50.0) | 33 (97.1) | 0.008[ |
| Male | 3 (50.0) | 1 (2.9) | |
| Laterality | |||
| Right | 4 (66.7) | 16 (47.1) | 0.661[ |
| Left | 2 (33.3) | 18 (52.9) | |
| NCV | 0.049[ | ||
| Mild (grade 2) | 0 | 3 (8,8) | |
| Moderate (grade 3) | 0 | 10 (29.4) | |
| Severe (grade 4) | 3 (50.0) | 4 (11.8) | |
| Very severe (grade 5) | 2 (33.3) | 6 (17.7) | |
| Extremely severe (grade 6) | 0 | 9 (26.5) | |
| No data | 1 (16.7) | 2 (5.9) |
Values are presented as mean±SD or number (%).
BCTQ, Boston Carpal Tunnel Syndrome Questionnaire; BT, bleeding tendency; NCV, nerve conduction velocity.
Independent t-test;
Chi-square test;
Fisher exact test.
Analysis of BCTQ scores
| Parameter | Preoperative | 3 Months after surgery[ | Final follow-up[ |
|---|---|---|---|
| SSS | 3.89 ± 0.80 | 1.41 ± 0.95 | 1.18 ± 0.40 |
| FSS | 3.50 ± 1.61 | 1.31 ± 0.85 | 1.24 ± 0.69 |
| Total | 3.70 ± 1.06 | 1.36 ± 0.86 | 1.21 ± 0.52 |
Values are presented as mean±SD.
BCTQ, Boston Carpal Tunnel Syndrome Questionnaire; SSS, symptom severity scale; FSS, functional status scale.
The results of comparison with preoperative scores (paired t-test) were statistically significant (P<0.01).
Analysis of the preoperative homogeneity of BCTQ scores
| Parameter | Bleeding tendency | No bleeding tendency | P-value |
|---|---|---|---|
| SSS | 3.68 ± 0.66 | 3.92 ± 0.82 | 0.494 |
| FSS | 3.04 ± 1.27 | 3.58 ± 1.67 | 0.455 |
| Total | 3.36 ± 0.92 | 3.76 ± 1.08 | 0.408 |
Values are presented as mean±SD.
BCTQ, Boston Carpal Tunnel Syndrome Questionnaire; SSS, symptom severity scale; FSS, functional status scale.
Comparison of BCTQ scores
| Parameter | 3 Months after surgery | Final follow-up | Source | P-value |
|---|---|---|---|---|
| SSS | G | 0.644 | ||
| Bleeding tendency | 1.18 ± 0.40 | 1.18 ± 0.40 | T | 0.414 |
| No bleeding tendency | 1.45 ± 1.02 | 1.18 ± 0.41 | G × T | 0.414 |
| FSS | G | 0.383 | ||
| Bleeding tendency | 1.04 ± 0.10 | 1.00 ± 0.00 | T | 0.323 |
| No bleeding tendency | 1.36 ± 0.92 | 1.29 ± 0.74 | G × T | 0.801 |
| Total | G | 0.475 | ||
| Bleeding tendency | 1.11 ± 0.20 | 1.09 ± 0.20 | T | 0.371 |
| No bleeding tendency | 1.40 ± 0.93 | 1.23 ± 0.56 | G × T | 0.485 |
Values are presented as mean±SD.
BCTQ, Boston Carpal Tunnel Syndrome Questionnaire; SSS, symptom severity scale; FSS, functional status scale; G, bleeding tendency vs. no bleeding tendency; T, 3 months vs. final follow-up; G×T, interaction for G and T.
P-value by repeated-measures analysis of variance.